Online Course
on demand
24
Nov
2023
25
Nov
2023
Diagnostics & Molecular Oncology
Molecular Diagnostics, Genomics in Cancer Online Course 2023
Chairs
Matti Aapro, CH – Joseph Gligorov, FR – Frederique Penault-Llorca, FR
 
Date
Friday 24 and Saturday 25 November 2023

Background
Following the success of the course "Molecular Diagnostics, Genomics in Breast Cancer 2021", which had more than 2200 registrations and 700 participants connected live from more than 100 countries, SPCC is pleased to propose a second edition in 2023 focusing on: 
• Breast Cancer: pathology, molecular and multigene testing, clinical decision making with tests and clinical case discussion
• Other Cancers: markers for tailored treatment and clinical discussion on applicability and guidance from experts with live audience discussion
 
Learning Objectives
• Improving care for patients with breast and other cancers
• Discussing recent updates in molecular diagnostics in breast and other cancers
• Practicing thanks to case discussions with experts
 
Target Group
Geneticists - Pathologists - Clinical Oncologists - Medical Oncologists - Haemato-Oncologists - Surgeons - Nurses - Patient Advocates – Radiologists – Epidemiologists - Molecular Biologists
 
Course Format
The course, consisting of 2 consecutive days of live sessions, will be held online with the participation of world-renowned experts.
It will be free of charge and can be accessed by registering on SPCC's OncoCorner e-learning platform. The material will remain available on-demand.

Continuing Medical Education accreditation
Application for CME accreditation has been submitted to the Accreditation Council of Oncology in Europe (ACOE).
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 5 CME credits.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.

Acknowledgements
Sharing Progress in Cancer Care wishes to express its appreciation to Exact Sciences, Novartis and Veracyte for their support with unconditional educational grants.
Supporters have no input into speakers, the agenda or content for the programme.
24/11/2023 15:00 CET

DAY 1 - Breast and gynaecological cancer

24/11/2023 15:00 CET

Welcome and introduction

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
24/11/2023 15:05 CET

How much information can we gain from classical pathology?

Expert: Roberto Salgado, BE
24/11/2023 15:25 CET

Molecular and multigene testing in early breast cancer – where do we stand?

Expert: Frédérique Penault-Llorca, FR
24/11/2023 15:45 CET

Molecular gynaecological pathway: ovarian carcinoma with HRD, endometrial carcinoma with MSI HER2, and PD-L1 cervical carcinoma

Expert: Xavier Matias-Guiu Guia, ES
24/11/2023 16:05 CET

Clinical decision-making assisted by molecular/multigene testing in early breast cancer

Expert: Nadia Harbeck, DE
24/11/2023 16:25 CET

Educational sessions discussion and Q&A

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
Expert: Xavier Matias-Guiu Guia, ES
Expert: Roberto Salgado, BE
24/11/2023 16:50 CET

Groups Session: Patient Cases discussion on Early Breast Cancer

Case 1: woman 29 years old
Case 2: woman 73 years old
Case 3: woman 45 years old
Case 4: woman 55 years old
Expert: Sana Al Sukhun, JO
Expert: Maria-João Cardoso, PT
Expert: Nagi S. El Saghir, LB
Expert: Orit Kaidar-Person, IL
Expert: Melanie Machiels, BE
Expert: Giancarlo Pruneri, IT
Expert: Isabel T. Rubio, ES
Expert: Roberto Salgado, BE
Moderator: Joseph Gligorov, FR
Moderator: Nadia Harbeck, DE
25/11/2023 15:00 CET

DAY 2 - Other cancers

25/11/2023 15:00 CET

Welcome and introduction

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
25/11/2023 15:05 CET

Thyroid Cancer; what to ask for in order to give the appropriate treatment (if available)

Expert: Aleš Ryška, CZ
25/11/2023 15:25 CET

Educational session discussion and Q&A

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
Expert: Aleš Ryška, CZ
25/11/2023 15:45 CET

Lung Cancer; what to ask for in order to give the appropriate treatment (if available)

Expert: Fernando Lopez-Rios, ES
25/11/2023 16:05 CET

Educational session discussion and Q&A

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
Discussant: Vanita Noronha, IN
Discussant: Christian Rolfo, US
Expert: Fernando Lopez-Rios, ES
25/11/2023 16:25 CET

Colorectal Cancer; what to ask for in order to give the appropriate treatment (if available)

Expert: Magali Svrcek, FR
25/11/2023 16:45 CET

Educational session discussion and Q&A

Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frédérique Penault-Llorca, FR
Discussant: Eric Van Cutsem, BE
Expert: Magali Svrcek, FR
25/11/2023 17:05 CET

Closure

Matti Aapro
Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland
Sana Al Sukhun
Al Hyatt Oncology Practice, Amman, Jordan
Maria-João Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Nagi S. El Saghir
American University of Beirut Medical Center, Beirut, Lebanon
Joseph Gligorov
Hospital Tenon Ap-Hp, Paris, France
Nadia Harbeck
Breast Center, LMU University Hospital, Munich, Germany
Orit Kaidar-Person
Sheba Medical Center, Ramat Gan, Israel
Fernando Lopez-Rios
Department of Pathology at "12 de Octubre" University Hospital, Madrid, Spain
Melanie Machiels
Radiation Oncologist at Iridium Netwerk, University of Antwerp, Wilrijk, Belgium
Xavier Matias-Guiu Guia
University of Barcelona, Barcelona, Spain
Vanita Noronha
Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Frédérique Penault-Llorca
Jean Perrin Center, Clermont-Ferrand, France
Giancarlo Pruneri
Fondazione IRCCS, Istituto Nazionale Tumori and University of Milan, Milan, Italy
Christian Rolfo
Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, The Ohio State University, Columbus, USA
Isabel T. Rubio
Clínica Universidad de Navarra, President-Elect of the European Cancer Organisation (ECO), Madrid, Spain
Aleš Ryška
Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic
Roberto Salgado
GZA Hospitals, Antwerp, Belgium
Magali Svrcek
Sorbonne University, Paris, France
Eric Van Cutsem
University of Leuven, Leuven, Belgium
Login for the Online Course